GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alar Pharmaceuticals Inc (ROCO:6785) » Definitions » Purchase Of Business

Alar Pharmaceuticals (ROCO:6785) Purchase Of Business : NT$0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Alar Pharmaceuticals Purchase Of Business?

Alar Pharmaceuticals's purchase of business for the three months ended in Mar. 2025 was NT$0.00 Mil. It means Alar Pharmaceuticals spent NT$0.00 Mil on purchasing business. Alar Pharmaceuticals's purchase of business for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0.00 Mil.

Compared with last quarter (NT$0.00 Mil in Dec. 2024 ), Alar Pharmaceuticals spent the same money on purchasing business in Mar. 2025 (NT$0.00 Mil).

Alar Pharmaceuticals Purchase Of Business Historical Data

The historical data trend for Alar Pharmaceuticals's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alar Pharmaceuticals Purchase Of Business Chart

Alar Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Business
Get a 7-Day Free Trial - - - - -30.00

Alar Pharmaceuticals Quarterly Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alar Pharmaceuticals Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alar Pharmaceuticals Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Alar Pharmaceuticals's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Alar Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alar Pharmaceuticals Inc (ROCO:6785) » Definitions » Purchase Of Business
Comparable Companies
TPE:4119 TPE:4746 ROCO:1799 ROCO:4166 ROCO:6576 TPE:1720 ROCO:6932 ROCO:6620 ROCO:4120 ROCO:4747 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 32, Keya Road, 5th Floor, Daya District, Taichung, TWN, 407
Website
https://www.alarpharm.com
Alar Pharmaceuticals Inc is a drug development company. It focuses on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and depressive disorder. These chronic diseases not only cause long-term burdens to the patients and their families but also consume huge social costs.

Alar Pharmaceuticals Headlines

No Headlines